Effects of intraperitoneal mitomycin C adsorbed on activated carbon on adhesion formation and mesothelial cells in vitro

European Journal of Surgery

Volumn 166, Issue 7, 2000, Pages 572-576

  Jansen, Marc ^a,b   Fass, Jürgen ^a   Langejürgen, Elke ^a   Forsch, Sabine ^a   Tietze, Lothar ^a   Schumpelick, Volker ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Activated carbon; Adjuvant therapy; Animal experiments; Fibrinolytic parameters; Gastric cancer; In vitro experiments; Mitomycin C; Peritoneal dissemination; Septic complications

Indexed keywords

ACTIVATED CARBON; LACTATE DEHYDROGENASE; MITOMYCIN C; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR;

ADHESION; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ADSORPTION; ENZYME ACTIVITY; FIBRINOLYSIS; HUMAN; HUMAN CELL; INTESTINE ANASTOMOSIS; LAPAROTOMY; MESOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033942291     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/110241500750008664     Document Type: Article

References (16)

1. 1. Boku T, Nakane Y, Minoura T, et al. Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 1990; 77: 436-439.
2. 2. Buckmann RF, Woods M, Sargent L, Gervin AS. A unifying pathogenic mechanism in the aetiology of intraperitoneal adhesions. J Surg Res 1976; 20: 1-5.
3. 3. Fass J, Asshoff G, Zengel K, Reinicke Th, Schumpelick V. Prophylactic intraperitoneal therapy with carbon-adsorbed mitomycin in gastric cancer with serosal invasion. Preliminary results of a prospective randomised trial. In: Siewert JR, Roder JD eds.: Progress in Gastric Cancer Research 1997. Munich: Monduzzi Editore 1997: 1359-1364.
4. 4. Fujimoto S, Shresta RD, Kokubun M, et al. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988; 208: 36-41.
5. 5. Fujimura T, Yonemura Y, Muraoka K, et al. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomised controlled study. World J Surg 1994; 18: 150-155.
6. 6. Graf W, Weiber S, Glimelius B, Jiborn H, Pahlman L, Zederfeldt B. Influence of 5-fluorouracil and folinic acid on colonic healing: an experimental study in the rat. Br J Surg 1992; 79: 825-828.
7. 7. Hagiwara A, Takahashi T, Lee R, Ueda T, Takeda M, Itoh T. Chemotherapy for carcinomatous peritonitis and pleuritis with MMC-CH, Mitomycin C adsorbed on activated carbon particles; Clinical trials. Cancer 1987; 59: 245-251.
8. 8. Hagiwara A, Takahashi T, Ueda T, Lee R, Takeda M, Itoh T. Intraoperative chemotherapy with carbon particles adsorbing mitomycin C for gastric cancer with peritoneal dissemination in rabbits. Surgery 1988; 104: 874-881.
9. 9. Hagiwara A, Takahashi T, Kojima O, et al. Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet 1992; 339: 629-631.
10. 10. Hinsbergh VWM, Kooistra T, Scheffer AA, van Bockel JH, van Muijen GNP. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990; 75: 1490-1497.
11. 11. Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 1988; 61: 232-237.
12. 12. Maruyama K. Results of surgery correlated with staging. In: Preece PE, Cuschieri A, Wellwood JM eds., Cancer of the stomach. London: Grune and Strattion, 1986: 145-163.
13. 13. Thompson JN, Paterson-Brown S, Harbourne T, Whawell SA, Kalodiki E, Dudley HAF. Reduced human peritoneal plasminogen activating activity: Possible mechanism of adhesion formation. Br J Surg 1989; 76: 382-384.
14. 14. Tietze L, Elbrecht A, Schauerte C, et al. Modulation of pro-and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor ß1 (TGF-ß1), Tumor necrosis factor a (TNF-a) and Interleukin 1ß (IL-1ß). Thromb Haemost 1998; 79: 362-370.
15. 15. Vipond MM, Whawell SA, Thompson JN, Dudley HAF. Peritoneal fibrinolytic activity and intraabdominal adhesions. Lancet 1990; 335: 1120-1122.
16. 16. Yonemura Y, Fujimura T, Fushida S, et al. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991; 15: 530-536.